Since in CLL cells, IL-6 promotes CLL cells’ survival, we postulated that by activating the β-catenin pathway, endothelial cells become “micro-factories” for the production of humoral IL-6. Here, IL6 is linked to B-cell chronic lymphocytic leukemia.